DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $191,436 | -8.6% | 15,050 | +1.2% | 0.00% | – |
Q2 2023 | $209,370 | -18.5% | 14,870 | -10.5% | 0.00% | -100.0% |
Q1 2023 | $256,779 | -5.7% | 16,620 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $272,402 | -32.1% | 16,620 | -23.4% | 0.00% | 0.0% |
Q3 2022 | $401,000 | +40.7% | 21,700 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $285,000 | +41.8% | 21,700 | +0.0% | 0.00% | – |
Q1 2022 | $201,000 | -5.2% | 21,690 | 0.0% | 0.00% | – |
Q4 2021 | $212,000 | -71.2% | 21,690 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $737,000 | -6.4% | 21,690 | +0.8% | 0.00% | 0.0% |
Q2 2021 | $787,000 | +8.3% | 21,510 | +32.6% | 0.00% | 0.0% |
Q1 2021 | $727,000 | -19.1% | 16,219 | +2.9% | 0.00% | -50.0% |
Q4 2020 | $899,000 | +7.8% | 15,759 | -3.0% | 0.00% | 0.0% |
Q3 2020 | $834,000 | +2.3% | 16,249 | +19.0% | 0.00% | 0.0% |
Q2 2020 | $815,000 | +206.4% | 13,649 | +111.0% | 0.00% | +100.0% |
Q1 2020 | $266,000 | -32.3% | 6,468 | +2.4% | 0.00% | 0.0% |
Q4 2019 | $393,000 | – | 6,318 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |